Updates in Germline Clinical Testing for Breast Cancer

January 2, 2018

This video reviews studies investigating the use of germline clinical testing for breast cancer.

In this video, Julie Nangia, MD, of Baylor College of Medicine in Houston, highlights abstracts investigating the use of germline clinical testing for breast cancer, including a study on general population testing and more.

Nangia was a discussant for a spotlight session on this topic at the 2017 San Antonio Breast Cancer Symposium (SABCS), held December 5–9 in San Antonio, Texas.

Updates in Germline Clinical Testing for Breast Cancer

Julie Nangia, MD

Significant Interfacility Variation Found in Implementation of Low-Value Breast Cancer Procedures

Black Women With Node-Negative Breast Cancer More Likely to Have High-Risk Recurrence Scores Than Non-Hispanic White Women

Phase 3 OlympiA Trial for HER2-Negative Breast Cancer Moves to Early Primary Analysis Per IDMC Recommendation